Sonendo, Inc. (SONX)

Sonendo, Inc. (SONX) — VMCI valuation read

Sonendo, Inc. sits at VMCI 43/100, with the Healthcare sector median at 50. That 7-point spread is the first thing to note on SONX: it tells the reader the composite is unfavorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on SONX are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on SONX: SONX trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of -1.4x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.

SONX fell 1.2% over the trailing 7 days, with a -0.5% read on a 30-day basis.